Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
-
-
-
-
-
-
-
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
-
-
-
-
-
-
-
GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
-
-
-
-
-
-
-
BTIG stays Buy rated on NRx Pharmaceuticals, Inc. (NRXP) as FDA waives additional clinical trials
-
-
-
-
-
-
-
NRx Pharmaceuticals meets with FDA on suicidal depression drug
-
-
-
-
-
-
-
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
-
-
-
-
-
-
-
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of
-
471,222 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


